-
公开(公告)号:US07173004B2
公开(公告)日:2007-02-06
申请号:US10825693
申请日:2004-04-16
申请人: Fiona McPhee , Jeffrey Allen Campbell , Stanley D'Andrea , Zhizhen Barbara Zheng , Andrew Charles Good , David J. Carini , Barry L. Johnson , Paul Michael Scola , Kenneth M. Boy
发明人: Fiona McPhee , Jeffrey Allen Campbell , Stanley D'Andrea , Zhizhen Barbara Zheng , Andrew Charles Good , David J. Carini , Barry L. Johnson , Paul Michael Scola , Kenneth M. Boy
IPC分类号: A61K38/00
CPC分类号: C07K5/0804 , A61K38/00 , C12P7/62 , C12P13/04 , C12P41/005
摘要: Macrocyclic isoquinoline peptides are disclosed having the general formula:A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的大环异喹啉肽:式I化合物:其中R 1至R 9,Q和W在说明书中描述。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
公开(公告)号:US07741281B2
公开(公告)日:2010-06-22
申请号:US11591253
申请日:2006-11-01
申请人: Stanley D'Andrea , Zhizhen Barbara Zheng , Jeffrey Allen Campbell , Fiona McPhee , Andrew Charles Good , Paul Michael Scola
发明人: Stanley D'Andrea , Zhizhen Barbara Zheng , Jeffrey Allen Campbell , Fiona McPhee , Andrew Charles Good , Paul Michael Scola
IPC分类号: A61K38/00
CPC分类号: A61K38/204 , A61K38/2013 , A61K38/208 , A61K38/212 , C07K5/06139 , C07K5/0804 , A61K2300/00
摘要: Macrocyclic peptides are disclosed having the general formula: wherein R′, R3, R3′, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的大环肽:其中描述了R',R 3,R 3',R 4,R 6,X,Q和W。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
公开(公告)号:US07132504B2
公开(公告)日:2006-11-07
申请号:US10985106
申请日:2004-11-10
申请人: Paul Michael Scola , Fiona McPhee , Nicholas A Meanwell , Piyasena Hewawasam , Jeffrey Allen Campbell
发明人: Paul Michael Scola , Fiona McPhee , Nicholas A Meanwell , Piyasena Hewawasam , Jeffrey Allen Campbell
IPC分类号: A61K38/00
CPC分类号: C07K5/0808 , A61K38/00 , C07K5/0802
摘要: Compounds are disclosed having the general formula: wherein R1, R2, R3, R4, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的化合物:其中R 1,R 2,R 3,R 4,R ',B,Y和X在说明书中描述。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
公开(公告)号:US20050090432A1
公开(公告)日:2005-04-28
申请号:US10825693
申请日:2004-04-16
申请人: Fiona McPhee , Jeffrey Campbell , Wenying Li , Stanley D'Andrea , Zhizhen Zheng , Andrew Good , David Carini , Barry Johnson , Paul Scola
发明人: Fiona McPhee , Jeffrey Campbell , Wenying Li , Stanley D'Andrea , Zhizhen Zheng , Andrew Good , David Carini , Barry Johnson , Paul Scola
IPC分类号: A61K38/00 , A61K38/12 , C07K20060101 , C07K5/083 , C07K5/12 , C07K7/00 , C12P7/62 , C12P13/04 , C12P41/00
CPC分类号: C07K5/0804 , A61K38/00 , C12P7/62 , C12P13/04 , C12P41/005
摘要: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的大环异喹啉肽:式I化合物:其中R 1至R 9,Q和W在说明书中描述。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
公开(公告)号:US20070099825A1
公开(公告)日:2007-05-03
申请号:US11591253
申请日:2006-11-01
申请人: Stanley D'Andrea , Zhizhen Zheng , Jeffrey Campbell , Fiona McPhee , Andrew Good , Paul Scola
发明人: Stanley D'Andrea , Zhizhen Zheng , Jeffrey Campbell , Fiona McPhee , Andrew Good , Paul Scola
CPC分类号: A61K38/204 , A61K38/2013 , A61K38/208 , A61K38/212 , C07K5/06139 , C07K5/0804 , A61K2300/00
摘要: Macrocyclic peptides are disclosed having the general formula: wherein R′, R3, R3′, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的大环肽:其中R',R 3,R 3',R 4,R 6, / SUP>,X,Q和W。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
公开(公告)号:US20110250176A1
公开(公告)日:2011-10-13
申请号:US12899840
申请日:2010-10-07
申请人: Julie A. Lemm , Stacey A. Voss , Min Gao , Susan E. Chaniewski , Amy K. Sheaffer , Fiona McPhee
发明人: Julie A. Lemm , Stacey A. Voss , Min Gao , Susan E. Chaniewski , Amy K. Sheaffer , Fiona McPhee
IPC分类号: A61K31/4725 , A61K31/7056 , A61P31/14 , A61K38/21
CPC分类号: A61K38/06 , A61K31/4178 , A61K45/06 , A61K2300/00
摘要: The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
摘要翻译: 本公开一般涉及抗病毒化合物,更具体地涉及可以抑制丙型肝炎病毒(HCV)的化合物的组合,包含这些化合物的组合物,以及使用这些组合治疗丙型肝炎的方法。
-
公开(公告)号:US08415374B2
公开(公告)日:2013-04-09
申请号:US12899840
申请日:2010-10-07
申请人: Julie A. Lemm , Stacey A. Voss , Min Gao , Susan E. Chaniewski , Amy K. Sheaffer , Fiona McPhee
发明人: Julie A. Lemm , Stacey A. Voss , Min Gao , Susan E. Chaniewski , Amy K. Sheaffer , Fiona McPhee
IPC分类号: A61K31/47 , A61K31/445
CPC分类号: A61K38/06 , A61K31/4178 , A61K45/06 , A61K2300/00
摘要: The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
摘要翻译: 本公开一般涉及抗病毒化合物,更具体地涉及可以抑制丙型肝炎病毒(HCV)的化合物的组合,包含这些化合物的组合物,以及使用这些组合治疗丙型肝炎的方法。
-
公开(公告)号:US20120196794A1
公开(公告)日:2012-08-02
申请号:US13195317
申请日:2011-08-01
申请人: Min Gao , David F. Gardiner , Julie A. Lemm , Fiona McPhee , Stacey A. Voss
发明人: Min Gao , David F. Gardiner , Julie A. Lemm , Fiona McPhee , Stacey A. Voss
摘要: The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations.
摘要翻译: 本公开通常涉及抗病毒化合物,更具体地涉及可以抑制丙型肝炎病毒(HCV)的化合物的组合,包含这些化合物的组合物,以及使用这种组合治疗丙型肝炎的方法。
-
公开(公告)号:US20050187165A1
公开(公告)日:2005-08-25
申请号:US10985106
申请日:2004-11-10
CPC分类号: C07K5/0808 , A61K38/00 , C07K5/0802
摘要: Compounds are disclosed having the general formula: wherein R1, R2, R3, R4, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要翻译: 公开了具有以下通式的化合物:其中R 1,R 2,R 3,R 4,R ',B,Y和X在说明书中描述。 还公开了包含化合物的组合物和使用该化合物抑制HCV的方法。
-
-
-
-
-
-
-
-